The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran
Globally, diabetic retinopathy (DR) is one of the leading causes of blindness, that diminishes quality of life. This study aimed to describe the prevalence of DR, and its associated risk factors. This cross-sectional study was carried out among 478 diabetic patients in a referral center in Fars prov...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Diabetes Association
2018-08-01
|
| Series: | Diabetes & Metabolism Journal |
| Subjects: | |
| Online Access: | https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-538.pdf |
| _version_ | 1818153280310607872 |
|---|---|
| author | Haleh Ghaem Nima Daneshi Shirin Riahi Mostafa Dianatinasab |
| author_facet | Haleh Ghaem Nima Daneshi Shirin Riahi Mostafa Dianatinasab |
| author_sort | Haleh Ghaem |
| collection | DOAJ |
| description | Globally, diabetic retinopathy (DR) is one of the leading causes of blindness, that diminishes quality of life. This study aimed to describe the prevalence of DR, and its associated risk factors. This cross-sectional study was carried out among 478 diabetic patients in a referral center in Fars province, Iran. The mean±standard deviation age of the participants was 56.64±12.45 years old and DR prevalence was 32.8%. In multivariable analysis, lower education levels (adjusted odds ratio [aOR], 0.43; 95% confidence interval [CI], 0.24 to 0.76), being overweight (aOR, 1.70; 95% CI, 1.02 to 2.83) or obese (aOR, 1.88; 95% CI, 1.09 to 3.26), diabetes duration of 10 to 20 years (aOR, 2.35; 95% CI, 1.48 to 3.73) and over 20 years (aOR, 5.63; 95% CI, 2.97 to 10.68), receiving insulin (aOR, 1.99; 95% CI, 1.27 to 3.10), and having chronic diseases (aOR, 1.71; 95% CI, 1.02 to 2.85) were significantly associated with DR. In conclusion, longer diabetes duration and obesity or having chronic diseases are strongly associated with DR suggesting that control of these risk factors may reduce both the prevalence and impact of retinopathy in Iran. |
| first_indexed | 2024-12-11T14:08:06Z |
| format | Article |
| id | doaj.art-4ef94aa731c241e5921126f4cb0218f0 |
| institution | Directory Open Access Journal |
| issn | 2233-6079 2233-6087 |
| language | English |
| last_indexed | 2024-12-11T14:08:06Z |
| publishDate | 2018-08-01 |
| publisher | Korean Diabetes Association |
| record_format | Article |
| series | Diabetes & Metabolism Journal |
| spelling | doaj.art-4ef94aa731c241e5921126f4cb0218f02022-12-22T01:03:35ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872018-08-0142653854310.4093/dmj.2018.0047The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern IranHaleh Ghaem0Nima Daneshi1Shirin Riahi2Mostafa Dianatinasab3Research Center for Health Sciences, Institute of Health, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, .IranBehbahan Faculty of Medical Sciences, Behbahan, .IranNon-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, .IranCenter for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, .IranGlobally, diabetic retinopathy (DR) is one of the leading causes of blindness, that diminishes quality of life. This study aimed to describe the prevalence of DR, and its associated risk factors. This cross-sectional study was carried out among 478 diabetic patients in a referral center in Fars province, Iran. The mean±standard deviation age of the participants was 56.64±12.45 years old and DR prevalence was 32.8%. In multivariable analysis, lower education levels (adjusted odds ratio [aOR], 0.43; 95% confidence interval [CI], 0.24 to 0.76), being overweight (aOR, 1.70; 95% CI, 1.02 to 2.83) or obese (aOR, 1.88; 95% CI, 1.09 to 3.26), diabetes duration of 10 to 20 years (aOR, 2.35; 95% CI, 1.48 to 3.73) and over 20 years (aOR, 5.63; 95% CI, 2.97 to 10.68), receiving insulin (aOR, 1.99; 95% CI, 1.27 to 3.10), and having chronic diseases (aOR, 1.71; 95% CI, 1.02 to 2.85) were significantly associated with DR. In conclusion, longer diabetes duration and obesity or having chronic diseases are strongly associated with DR suggesting that control of these risk factors may reduce both the prevalence and impact of retinopathy in Iran.https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-538.pdfDiabetesDiabetes durationDiabetic retinopathyInsulinPrevalenceRisk factors |
| spellingShingle | Haleh Ghaem Nima Daneshi Shirin Riahi Mostafa Dianatinasab The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran Diabetes & Metabolism Journal Diabetes Diabetes duration Diabetic retinopathy Insulin Prevalence Risk factors |
| title | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
| title_full | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
| title_fullStr | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
| title_full_unstemmed | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
| title_short | The Prevalence and Risk Factors for Diabetic Retinopathy in Shiraz, Southern Iran |
| title_sort | prevalence and risk factors for diabetic retinopathy in shiraz southern iran |
| topic | Diabetes Diabetes duration Diabetic retinopathy Insulin Prevalence Risk factors |
| url | https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-538.pdf |
| work_keys_str_mv | AT halehghaem theprevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT nimadaneshi theprevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT shirinriahi theprevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT mostafadianatinasab theprevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT halehghaem prevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT nimadaneshi prevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT shirinriahi prevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran AT mostafadianatinasab prevalenceandriskfactorsfordiabeticretinopathyinshirazsoutherniran |